Recursion Pharmaceuticals, Inc. (RXRX) Earnings
NASDAQ·Healthcare·Biotechnology
$3.34
+4.87%
Mkt Cap $1.60B
EPS — Estimate vs Actual
Mkt Cap
$1.60B
P/E
—
Fwd P/E
—
P/S
24.14
Rev TTM
—
EPS TTM
-$1.20
NASDAQ·Healthcare·Biotechnology
$3.34
+4.87%
Mkt Cap $1.60B
Mkt Cap
$1.60B
P/E
—
Fwd P/E
—
P/S
24.14
Rev TTM
—
EPS TTM
-$1.20